The use of ceftobiprole in treatment pathways in Spain: An expert panel review

This publication has 33 references indexed in Scilit:

• Ceftobiprole, a new option for multidrug resistant microorganisms in the outpatient antimicrobial therapy setting
  Enfermedades Infecciosas y Microbiología Clínica, 2022
• Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020
  Diagnostic Microbiology and Infectious Disease, 2022
• Surveillance of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2018 from different European territories
  Journal of Global Antimicrobial Resistance, 2021
• A Contemporary Picture of Enterococcal Endocarditis
  JACC, 2020
• Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016–2017)
  Diagnostic Microbiology and Infectious Disease, 2019
• Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013–2015
  European Journal of Clinical Microbiology & Infectious Diseases, 2018
• Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
  Enfermedades Infecciosas y Microbiología Clínica, 2017
• Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study
  Clinical Microbiology and Infection, 2016
• Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays
  International Journal of Antimicrobial Agents, 2014
• A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation
  International Journal of Antimicrobial Agents, 2012